Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03244631 · ClinicalTrials.gov registry record · NA

Pain Control in Hip Arthroscopy: Comparing Lumbar Plexus Versus Peri-capsular Injection

A NA study of Hip Arthroscopy and Nerve Block, sponsored by Washington Orthopaedics and Sports Medicine.

Completed
Registry status
NA
Development phase
64
Enrollment target
1
Study location

NCT03244631 is a NA study of Hip Arthroscopy and Nerve Block that has completed, run by Washington Orthopaedics and Sports Medicine. The registered enrollment target is 64 participants, below the 1,121-participant average among 10 other Hip Arthroscopy trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03244631, a NA study of Hip Arthroscopy and Nerve Block, has completed, sponsored by Washington Orthopaedics and Sports Medicine.

COMPLETED
Registry status
NA
Development phase
64 participants
Enrollment target
1
Study location

Study Summary

Comparison of lumbar plexus nerve block versus pericapsular injection for pain control during hip arthroscopy

Interventions

  • PROCEDURE Lumbar Plexus BLock
  • PROCEDURE Pericapsular injection

Study Locations (1)

Maryland

  • Washington Orthopedics and Sports Medicine - Chevy Chase

Trial Details

FieldValue
Enrollment Target 64 participants
Start Date 2017-09-26
Est. Completion 2020-02-01
Phase NA

What the Registry Record Tells You About NCT03244631

The ClinicalTrials.gov registry entry for NCT03244631 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 64 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,121-participant average among 10 other Hip Arthroscopy trials with a reported enrollment target (94% lower). The listed sponsor is Washington Orthopaedics and Sports Medicine, which has 1 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Hip Arthroscopy appearing as the primary indexed condition, and to 2 interventions - of which Lumbar Plexus BLock is the first listed.

NCT03244631 reports 1 study location spanning 1 distinct geographic area - top geographies include Maryland.

Frequently Asked Questions

What is clinical trial NCT03244631 about?

NCT03244631 is a clinical study titled "Pain Control in Hip Arthroscopy: Comparing Lumbar Plexus Versus Peri-capsular Injection". Comparison of lumbar plexus nerve block versus pericapsular injection for pain control during hip arthroscopy

What is the current status of trial NCT03244631?

This trial is currently completed. It is a NA study. The enrollment target is 64 participants. The study started on 2017-09-26. Estimated completion is 2020-02-01.

What conditions does trial NCT03244631 study?

This clinical trial studies the following conditions: Hip Arthroscopy, Nerve Block.

What interventions are being tested in trial NCT03244631?

The interventions under investigation include: Lumbar Plexus BLock (PROCEDURE), Pericapsular injection (PROCEDURE).

Who is sponsoring clinical trial NCT03244631?

This trial is sponsored by Washington Orthopaedics and Sports Medicine, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03244631 being conducted?

This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Hip Arthroscopy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.